Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites
- 1 June 1984
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 101 (3-4), 209-214
- https://doi.org/10.1016/0014-2999(84)90158-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Aspirin as an Antithrombotic MedicationNew England Journal of Medicine, 1983
- Platelet Thromboxane Synthetase Inhibitors with Low Doses of Aspirin: Possible Resolution of the "Aspirin Dilemma"Science, 1983
- Two metabolites of sulphinpyrazone and their identification and determination by mass spectrometryJournal of Pharmacy and Pharmacology, 1981
- Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.JCI Insight, 1981
- Long-lasting inhibition of platelet prostaglandin but normal vascular prostacyclin generation following sulphinpyrazone administration to ratsJournal of Pharmacy and Pharmacology, 1980
- SulfinpyrazoneDrugs, 1980
- Prostaglandins as Inhibitors of Human Platelet AggregationBritish Journal of Haematology, 1979
- The Inhibitory Effect of Aspirin on Platelet and Vascular Prostaglandins in Rats cannot be Completely DissociatedBritish Journal of Haematology, 1979
- The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivoThrombosis Research, 1978
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978